Assessment of Physical Performance After Oral Supplementation of Magnesium in a Sample of Old Women in Good Health

Sponsor
University of Padova (Other)
Overall Status
Completed
CT.gov ID
NCT01971424
Collaborator
(none)
100
1
2
14
7.2

Study Details

Study Description

Brief Summary

Magnesium deficiency is associated also in the elderly with low physical performance; nevertheless trials about the effect of supplementation of magnesium on physical performance are not available in old people. The aim of our study is to investigate whether 12-weeks of oral magnesium supplementation improves physical performance in healthy elderly women

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Mg oxide
  • Other: healthy diet
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mg oxide

Participants were supplemented for 12-weeks with 300 mg of daily oral magnesium oxide.

Dietary Supplement: Mg oxide
Other Names:
  • Magnesium oxide
  • Other: healthy diet

    No Intervention: Controls

    The control group was educated by a trained dietician to follow a healthy diet.

    Outcome Measures

    Primary Outcome Measures

    1. Changes in short physical performance battery (SPPB) [Baseline and after 12 weeks]

    Secondary Outcome Measures

    1. Changes in appendicular skeletal mass (ASMMI) [Baseline and after 12 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • People over 65 years, not residents in nursing home, in good health
    Exclusion Criteria:
    • previous supplementation of calcium, potassium or magnesium

    • use of pump proton inhibitors or digitalis

    • important co-mordidities such renal failure

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Geriatrics Division, Department of Medicine Padova Italy 35128

    Sponsors and Collaborators

    • University of Padova

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Giuseppe Sergi, Medical Doctor, University of Padova
    ClinicalTrials.gov Identifier:
    NCT01971424
    Other Study ID Numbers:
    • 2011491
    First Posted:
    Oct 29, 2013
    Last Update Posted:
    Oct 29, 2013
    Last Verified:
    Oct 1, 2013
    Keywords provided by Giuseppe Sergi, Medical Doctor, University of Padova
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 29, 2013